Advertisement
Advertisement
FTH
F
Faeth Therapeutics, Inc. Common Stock
24.54
USDSponsored
+0.54
+2.25%
Jun 24, 16:00 UTC -4
Closed
Pre-Market
26.70
+2.16
+8.82%
FTH Earnings Reports
Positive Surprise Ratio
FTH beat 1 of 2 last estimates.
50%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$6.52
Implied change from Q1 26 (Revenue/ EPS)
--
/-77.35%
Implied change from Q2 25 (Revenue/ EPS)
--
/+66.75%
Faeth Therapeutics, Inc. Common Stock earnings per share and revenue
On May 15, 2026, FTH reported earnings of -28.79 USD per share (EPS) for Q1 26, missing the estimate of -0.63 USD, resulting in a -4452.50% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -6.52 USD, with revenue projected to reach -- USD, implying an decrease of -77.35% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Odyssey Therapeutics, Inc. Common Stock
Report Date
Jun 17, 2026 For Q1 26
Estimate
-$1.27
Actual
-$6.77
Surprise
-429.90%
Aimei Health Technology Co., Ltd Ordinary Share
Report Date
Jun 16, 2026 For Q1 26
Estimate
-Actual
$0.01
Surprise
-
Suncrete, Inc. Class A Common Stock
Report Date
Jun 24, 2026 For Q1 26
Estimate
$0.04
Actual
-$0.06
Surprise
-247.06%
Aimei Health Technology Co., Ltd Unit
Report Date
Jun 16, 2026 For Q1 26
Estimate
-Actual
$0.01
Surprise
-
Cerebras Systems Inc. Class A Common Stock
Report Date
Jun 23, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.04
Surprise
+75.67%
Sunbelt Rentals Holdings, Inc.
Report Date
Jun 23, 2026 For Q4 26
Estimate
$0.75
Actual
$0.74
Surprise
-2.54%
Fervo Energy Company Class A common stock
Report Date
Jun 22, 2026 For Q1 26
Estimate
-$0.07
Actual
-$3.72
Surprise
-5169.12%
HawkEye 360, Inc.
Report Date
Jun 22, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.44
Surprise
-684.31%
FAQ
What were Faeth Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Faeth Therapeutics, Inc. Common Stock reported EPS of -$28.79, missing estimates by -4452.5%, and revenue of $0.00, 0% as expectations.
How did the market react to Faeth Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Faeth Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Faeth Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Faeth Therapeutics, Inc. Common Stock is expected to report EPS of -$6.52 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement